Back to top

Image: Bigstock

Patterson Companies' (PDCO) New Buyout to Expand Product Suite

Read MoreHide Full Article

Patterson Companies, Inc. (PDCO - Free Report) recently announced that it has, through a subsidiary, inked an agreement to acquire substantially all the assets of Dairy Tech, Inc. The acquired business is expected to expand Patterson Companies’ Animal Health’s product offerings.

Patterson Companies expects to close the transaction during the third quarter of fiscal 2023. However, the terms of the transaction have been kept under wraps.

Dairy Tech is a Colorado-based company that provides pasteurizing equipment and single-use bags that allow dairy producers to produce, store and feed colostrum for newborn calves. It also provides product offerings for beef cattle producers.

The acquired business will maintain its domestic and international commercial presence and will be boosted by Patterson Companies’ operational efficiencies.

The latest buyout is expected to significantly boost Patterson Companies’ Animal Health business across the world.

Rationale Behind the Acquisition

The latest acquisition is expected to expand Patterson Animal Health’s value-add platform by adding Dairy Tech’s products and solutions to its product suite.

Patterson Companies’ management believes that Dairy Tech’s innovative calf management program will likely bring significant value to its dairy and beef customers.

Industry Prospects

Per a report by Fortune Business Insights, the global animal health market was valued at approximately $41.50 billion in 2018 and is anticipated to reach $67.56 billion by 2026 at a CAGR of 6.3%. Factors like increased production of animal-based food items, the introduction of effective information management systems and technological advances are likely to drive the market.

Given the market potential, the latest agreement is expected to significantly strengthen Patterson Companies’ business worldwide.

Recent Developments

This month, Patterson Companies announced that it has, through a subsidiary, inked an agreement to acquire substantially all of the assets of Relief Services for Veterinary Practitioners and Animal Care Technologies. The acquired business will be integrated into Patterson Veterinary’s existing operations.

Patterson Companies announced its first-quarter fiscal 2023 results in September, where it registered robust internal sales growth year over year. This was driven by mid-single-digit growth in companion animal and high-single-digit growth in production animal. The growth in internal sales of consumables, and equipment and software was also solid.

In June, Patterson Companies announced that its subsidiary, Patterson Veterinary Supply, partnered with Sea Turtle Conservancy to help support their mission of ensuring the survival of sea turtles worldwide.

Price Performance

Patterson Companies’ stock has lost 16.3% over the past year compared with the industry’s 14.7% decline and the S&P 500's 17.4% fall.

Zacks Investment Research
Image Source: Zacks Investment Research

Zacks Rank & Key Picks

Currently, Patterson Companies carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader medical space are AMN Healthcare Services, Inc. (AMN - Free Report) , ShockWave Medical, Inc. (SWAV - Free Report) and McKesson Corporation (MCK - Free Report) .

AMN Healthcare, carrying a Zacks Rank #2 (Buy) at present, has an estimated long-term growth rate of 3.3%. AMN’s earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters, the average beat being 10.9%.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

AMN Healthcare has gained 6.8% against the industry’s 36.9% decline in the past year.

ShockWave Medical, carrying a Zacks Rank #2 at present, has an estimated growth rate of 23.6% for 2023. SWAV’s earnings surpassed estimates in all the trailing four quarters, the average beat being 146.1%.

ShockWave Medical has gained 15.8% against the industry’s 30.2% decline over the past year.

McKesson, carrying a Zacks Rank #2 at present, has an estimated long-term growth rate of 10.1%. MCK’s earnings surpassed estimates in two of the trailing four quarters and missed the same in the other two, the average beat being 4.8%.

McKesson has gained 63.7% against the industry’s 14.7% decline over the past year.

Published in